Stephen K. Brannan - 22 May 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Steven Ledger, Attorney in Fact
Issuer symbol
SER
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
17 Jun 2025, 20:36:45 UTC
Previous filing
18 Mar 2024
Next filing
10 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brannan Stephen K. Director 601 GENOME WAY, SUITE 2001, HUNTSVILLE /s/ Steven Ledger, Attorney in Fact 17 Jun 2025 0001777631

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 22 May 2025 Common Stock 40,000 $5.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in substantially equal yearly installments beginning on the aniversary of the grant date such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.